| Financial Year |
March 31 2023 |
| Monetary Funds |
469,717,408.92 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
-- |
| Advances to Suppliers |
72,492,225.11 |
| Other Receivables |
245,167.81 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
165,970,504.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
708,425,306.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,350,167.24 |
| Investment Properties |
-- |
| Fixed Assetes |
74,349,009.52 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,653,296.91 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
205,273,701.07 |
| Total Assets |
913,699,007.29 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,018,646.35 |
| Accounts Received In Advance |
229,788,636.82 |
| Employee Compensation Payable |
6,183,597.84 |
| Taxes Payable |
185,877.57 |
| Interest Payable |
-- |
| Dividend Payable |
247,378.37 |
| Other payables |
4,715,684.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
241,892,443.27 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,911,038.17 |
| Total Liabilities |
246,803,481.44 |
| Paid-In Capital(Or Share Stock) |
292,578,000.00 |
| Capital Surplus |
23,193,875.92 |
| Surplus Reserve |
80,232,599.60 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
212,893,213.38 |
| Minority Stockholder's Interest |
59,343,578.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
607,551,947.69 |
| Owner's Equity（Stockholder's Equity） |
666,895,525.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
913,699,007.29 |
